stocktools
Dilution profile // every instrument, one screen, from SEC filings

GE HealthCare Technologies Inc. (GEHC)

CIK 1932393 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3ASR on file 2024-06-28
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW0% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2023-01-312026-04-22

Latest: 454.9M shares as of Apr 22, 2026 (10-Q).

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Jul 29, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

S-3ASRJun 28, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-3ASRFeb 15, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-3ASRFeb 9, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 2 executed · 0 registered.

EXECUTEDDec 2, 2025Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
EXECUTEDDec 1, 2025Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
MARKETINGDec 1, 2025Free-writing prospectus — offering being marketedFWP →
EXECUTEDJun 5, 2025Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
EXECUTEDJun 3, 2025Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
MARKETINGJun 3, 2025Free-writing prospectus — offering being marketedFWP →
UPDATENov 8, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
MARKETINGNov 7, 2024Free-writing prospectus — offering being marketedFWP →
UPDATESep 13, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →
MARKETINGSep 12, 2024Free-writing prospectus — offering being marketedFWP →
EXECUTEDAug 9, 2024Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →
EXECUTEDAug 7, 2024Prospectus supplement priced — shares or notes (large filers: often a bond deal)424B2 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full GEHC workspace